Filters

Phentolamine mesylate manufacturers

Filters

None products found

phentolamine mesylate

Injection 1 mg/ml, 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, ANVISA, INVIMA
Manufacturer #11735
Indian pharmaceutical manufacturer established in the 1980s with over four decades of experience producing Rx tablets, capsules, oral liquids, ointments, and eye drops. Exports to 80+ countries across Asia, Africa, Latin America, and CIS markets. Holds WHO-GMP, EU-GMP, PIC/s, ANVISA, COFEPRIS, and DIGEMID regulatory approvals.

Manufacturer usually replies in 14 days

phentolamine mesylate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
FDA
Manufacturer #21935

Founded in the 1990s, this manufacturer is a distinguished CTD dossier owner and manufacturer, serving both patients and healthcare professionals across the MENA and African regions. As a GMP manufacturer, it employs comprehensive healthcare solutions to improve the quality of human life. This CTD dossier owner and manufacturer operates under strict quality standards, ensuring the reliability of its products as a GMP manufacturer and CTD dossier owner and manufacturer.

 

Manufacturer usually replies in 47 days

phentolamine mesylate

Ampoules 10 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

Manufacturer usually replies in 27 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.